Is Vacation Good For Your Heart? Yes
Vacation is supposed to be the sort of downtime which is good to clear the mind and relieve tension. It apparently has physical health benefits as well, beyond whatever exercise the vacationer might do.…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 97
New Study Links Irregular Heartbeat and Dementia
A new large-scale study conducted by Korean researchers, the results of which were just published in the European Heart Journal, has established a significant link between the common cardiac arrhythmia called atrial fibrillation, or…
FDA Ignites Ocular Inflammation Treatment Dextenza in Most Recent Approval
Ocular Therapeutix shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the treatment of ocular inflammation…
Canadian Marijuana Use Jumps Even More Than Expected After Legalization
Marijuana trends showing higher use after cannabis legalization in Canada.
Study Shows How Pomegranates May Help Keep Us Younger
Swiss researchers have established that tannins found in pomegranates are converted in the digestive system into a compound that appears to slow down mitochondrial aging — a natural process that weakens cells and causes…
Why This FDA Approval for Pneumonia Treatment Is So Huge
Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review.
One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls
Analyst Yun Zhong looks at two treatments for Alzheimer Disease and other dementias that could beat the odds and be winners in treating these awful afflictions.
Tuesday’s Top BioPharma Movers Deviating from the Market
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus price target.
How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy
PhaseBio Pharmaceuticals shares jumped on Tuesday after the firm announced preliminary results from its mid-stage trial on subjects on dual antiplatelet therapy of ticagrelor and low-dose aspirin.
How Aclaris Is On Track to Treat Baldness
Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an answer to it in its most recent mid-stage clinical trial.
Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?
A blood pressure medication widely used in Europe and Japan might have potential to slow down the progress of Alzheimer’s disease, according to a new study appearing in Hypertension, a journal published by the…
How Much Is Pfizer Overpaying For Array Bio?
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger…
This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019
Annual deaths from cancer have dropped 27% in the last 25 years, according to the American Cancer Society (ACS). However, the death rates for some have barely dropped, and some forms will still kill…
It’s 119 Degrees In This City Now, And It’s Not Getting Better
Heat waves swung through Phoenix the week and pushed temperatures as high as 110 degrees Fahrenheit. In New Delhi, India, the temperature rose close to 120 but was pushed down fairly quickly by strong…